1. Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia

   • Ajoy Dias
   • Saad J. Kenderian
   • Mark R. Litzow

   Acute Lymphocytic Leukemias (K Ballen, Section Editor) 21 April 2016 Pages: 253 - 264

   

2. Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia

   • Manali I. Patel

   Health Economics (N Khera, Section Editor) 21 May 2016 Pages: 265 - 270

   

3. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

   • Gustavo F. Westin
   • Ajoy L. Dias
   • Ronald S. Go

   Health Economics (N Khera, Section Editor) 13 May 2016 Pages: 271 - 279

4. Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant

   • Anna Barata
   • William A. Wood
   • Heather S. L. Jim

   Health Economics (N Khera, Section Editor) 25 April 2016 Pages: 280 - 287

5. Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications

   • Jeffrey Betcher
   • Elizabeth Dow
   • Nandita Khera

   Health Economics (N Khera, Section Editor) 16 April 2016 Pages: 288 - 294

   

6. Bending the Cost Curve in Childhood Cancer

   • Heidi Russell
   • M. Brooke Bernhardt

   Health Economics (N Khera, Section Editor) 19 May 2016 Pages: 295 - 302

   

7. Value Based Care and Patient-Centered Care: Divergent or Complementary?

   • Eric K. Tseng
   • Lisa K. Hicks

   Health Economics (N Khera, Section Editor) 04 June 2016 Pages: 303 - 310

   

8. T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies

   • Nasheed M. Hossain
   • Aude G. Chapuis
   • Roland B. Walter

   CART and Immunotherapy (M Ruella, Section Editor) 19 April 2016 Pages: 311 - 317

9. Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies

   • Saar Gill

   CART and Immunotherapy (M Ruella, Section Editor) 02 May 2016 Pages: 318 - 325